A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Summary
- Eligibility
- for people ages 12-17 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Juan C. Alejos, MD

Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Juan C. Alejos, MD
HS Clinical Professor, Pediatrics, Medicine. Authored (or co-authored) 74 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Bristol-Myers Squibb
- Links
- BMS Clinical Trial Information BMS Clinical Trial Patient Recruiting Sign up for this study
- ID
- NCT06253221
- Phase
- Phase 3 Cardiomyopathy Research Study
- Study Type
- Interventional
- Participants
- Expecting 40 study participants
- Last Updated